Skip to content

Fucoidan(Seaweed) Based Gel Around Immediate Implants

Clinical And Radiographic Evaluation Of Fucoidan Gel Around Immediate Implants - A Randomized Control Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07736287
Enrollment
20
Registered
2026-07-30
Start date
2025-05-11
Completion date
2026-07-05
Last updated
2026-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Regeneration, Wound Healing

Brief summary

The current study is a prospective randomised parallel mouth study to evaluate the effect of Fucoidan gel around immediate implant to assess the wound healing and bone regeneration in comparison to regular implant placement without any gel.

Detailed description

Twenty healthy individuals satisfying the inclusion and exclusion criteria were recruited for the study. A detailed, thorough medical and dental history was obtained and each patient was subjected to comprehensive clinical and radiological examination. All patients were informed about the nature of the study, procedure involved, potential benefits and risks associated with procedure and written informed consent were obtained from all patients. All the patients underwent scaling and root planning. Following randomization, the site will be assigned to one of the two study groups. 1. test group(immediate implant+ fucoidan gel) 2. control group (only immediate implant without any gel)

Interventions

patients with immediate implant with Fucoidan gel coating prior to implant placement

PROCEDUREimmediate implant placement

patients with immediate implant without any implant surface coating prior to implant placement

Sponsors

Krishnadevaraya College of Dental Sciences & Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

life extension potimised fucodian capsules was used for this study

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients at least above 18 years of age. 2. Patients presenting with Stage I/II and Grade B periodontitis. 3. Class I extraction socket defects according to modified Elian et al 2021. 4. The recipient sites of the implant will be free from pathological conditions. 5. Patients who will comply with oral health care instructions and necessary visits 6. Cases undergoing extraction for dental caries or endodontic conditions.

Exclusion criteria

1. Uncontrolled diabetes and severe cardiovascular or infectious diseases 2. Patients with Intravenous and oral bisphosphonate therapy. 3. Patients who are unwilling to return for the follow-up examination. 4. Smokers, lactating and pregnant women. 5. Patients who are psychologically unable to participate. 6. Patients with poor oral hygiene.

Design outcomes

Primary

MeasureTime frameDescription
wound healing index after immediate implant placement7th day,14th day, 21st day, 1month, 3months and 6 monthsLandry, Turnbull and Howley wound healing index

Secondary

MeasureTime frameDescription
crestal bone levelbaseline, 3month and 6 monthusing RVG with 1 mm grid
gingival tissue thicknessbaseline , 3months and 6 months
keratinised tissue widthbaseline,3months and 6 months
CBCT : linear measurementbaseline and 6months
Plaque Index3months
Gingival Index3months
Modified sulcular bleeding index3 months
Probing depth (PD)1month,3month and 6 month

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 31, 2026